# Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

> **NCT00003397** · PHASE2 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 25 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** rituximab
- **BIOLOGICAL:** sargramostim
- **DRUG:** carmustine
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** dexamethasone
- **DRUG:** etoposide
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** melphalan
- **DRUG:** paclitaxel
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003397
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2002-12
- **Final completion:** 2002-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2019-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003397, "Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00003397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*